Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Abstract Text:

We investigated whether aliskiren, a direct renin inhibitor, improves NO bioavailability and protects against spontaneous atherosclerotic changes. We also examined the effects of cotreatment with aliskiren and valsartan, an angiotensin II receptor blocker, on the above-mentioned outcomes. Watanabe heritable hyperlipidemic rabbits were treated with vehicle (control), aliskiren, valsartan, or aliskiren plus valsartan for 8 weeks. Then, acetylcholine-induced NO production was measured as a surrogate index of endothelium protective function, and both superoxide and vascular peroxynitrite were measured. Tetrahydrobiopterin in aortic segments was assessed by high-performance liquid chromatography with fluorescence detection. Plaque area was quantified by histology. Increase in plasma NO concentration in response to intra-aortic acetylcholine infusion was significantly greater in all of the test groups than in controls. Aliskiren+valsartan cotreatment increased acetylcholine-induced NO by 6.2 nmol/L, which was significantly higher than that with either aliskiren or valsartan alone. Vascular superoxide and peroxynitrite levels were both significantly higher in controls and significantly lower in the aliskiren+valsartan group than in the aliskiren or valsartan group. The highest tetrahydrobiopterin levels were observed after aliskiren+valsartan cotreatment. Histology of the thoracic aorta revealed that the plaque area was significantly decreased with combination therapy compared with monotherapy. Treatment with a direct renin inhibitor has protective effects on endothelial function and atherosclerotic changes. Furthermore, cotreatment with a direct renin inhibitor and an angiotensin II receptor blocker has additive protective effects on both.

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hypertension

VOLUME: 52

Page Numbers: 563-72

Journal Abbreviation: Hypertension

ISSN: 1524-4563

DAY: 21

MONTH: 07

YEAR: 2008

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7906255

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.

AFFILIATION: Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan. t-imani@wakayama-med.ac.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hypertension

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes Related Publications

• Addition of eplerenone to an Angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability.
• Combined Effects of an 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor and Angiotensin II Receptor Antagonist on Nitric Oxide Bioavailability and Atherosclerotic Change in Myocardial Infarction-Prone Watanabe Heritable Hyperlipidemic Rabbits.
• Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
• Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits.
• Effects of Pioglitazone on Nitric Oxide Bioavailability Measured Using a Catheter-Type Nitric Oxide Sensor in Angiotensin II-Infusion Rabbit.
• Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease.
• Evaluation of pharmacological modulation of nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
• Functional tolerance of Streptomyces subtilisin inhibitor toward conformational and stability changes caused by single-point mutations in the hydrophobic core.
• Identification of multiple plaque ruptures by optical coherence tomography in a patient with acute myocardial infarction: a three-vessel study.
• Kinetic studies on acridine orange-DNA interaction. A branched mechanism involving intercalation and outside "dimerization".
• Necessity of Delivering the Calibration Coefficient of a Dosimeter for Low Energy X-rays Used in Mammography X-ray Units.
• Pioglitazone Inhibits Angiotensin II-Induced Senescence of Endothelial Progenitor Cell.
• Relationship between longitudinal morphology of ruptured plaques and TIMI flow grade in acute coronary syndrome: a three-dimensional intravascular ultrasound imaging study.
• Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
• Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography.
• Secondary structures and structural fluctuation in a dimeric protein, Streptomyces subtilisin inhibitor.
• Self association of Streptomyces subtilisin inhibitor: sedimentation equilibrium and 1H NMR studies.
• Structure of an unsaturated Fatty Acid with unique vicinal dimethyl branches isolated from the okinawan soft coral of the genus sinularia.
• The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease.
• [Surgical considerations of tetralogy of Fallot from the aspect of peripheral pulmonary arteries]
• [The Relationship between Subjective Evaluation and Objective Evaluation in the Examination of the Buccolingual Residual Ridge Shape of Edentulous Patients.]
• [Treated case of aortic valve regurgitation associated with Behçet's disease]